Expression of 5-Lipoxygenase in human colorectal cancer
- Author:
- No author available
- Journal Title:
- WORLD JOURNAL OF GASTROENTEROLOGY
- Issue:
- 39
- DOI:
- No doi available
- Key Word:
- Arachidonic acid;5-Lipoxygenase;Cyclooxygenase-2;Real time PCR;Immunohistochemistry;Colorectal cancer
Abstract： AIM: To evaluate the 5-lipoxygenases (Loxs) expression level in human colorectal cancer specimens in order to determine its clinicopathologic significance in human tumorigenesis.METHODS: The relative quantity of 5-Lox mRNA in paired 91 colorectal tumor and adjacent normal mucosa samples was determined by real time quantitative PCR. Additionally, the expression of 5-Lox and cyclooxygenase (Cox)-2 proteins was also examined using immunohistochemical staining methods.RESULTS: There was a marked increase in 5-Lox mRNA levels in the tumor compared with paired normal mucosa samples (P ＜ 0.0001). Sixty six (72.5%) tumors showed high 5-Lox mRNA levels. The positivity rate of 5-Lox and Cox-2 protein expression was 68.7% and 79.1%respectively. There was a significant association between tumoral 5-Lox mRNA level and tumor size (Rho = 0.392,P = 0.0002), depth or vessel invasion.CONCLUSION: These results suggest that 5-Lox is up-regulated in colorectal cancer and that inhibition of its expression might be valuable in the prevention and treatment of colorectal cancer.
- [1]R, Ohno,K, Yoshinaga,T, Fujita,etc.Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma.[J].2001,91(10).
- [2]Loprinzi CL,Keresztes R,Steinbach G,etc.A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.[J].2003,348(10).
- [3]de Alwis DP,Barile Thiem B,Brail L,etc.Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors.[J].2005,23(23).
- [4]G S, Jack,A R, Brash,S J, Olson,etc.Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.[J].2000,31(9).
- [5]Prescott SM,Cao Y.Many actions of cyclooxygenase-2 in cellular dynamics and in cancer.[J].2002,190(3).
- [6]S H, Hong,I, Avis,M D, Vos,etc.Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.[J].1999,59.
- [7]I, Shureiqi,K J, Wojno,J A, Poore,etc.Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.[J].1999,20.
- [8]Ghosh J,Myers CE.Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells.[J].1998,95(22).
- [9]Gordon GB,Hawk E,Wallace MH,etc.The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.[J].2000,342(26).
- [10]Chotteau-Lelievre A..Prognostic Value of ERM Gene Expression in Human Primary Breast Cancers[J].2004.
- [11]Steele VE,Holmes CA,Hawk ET,etc.Lipoxygenase inhibitors as potential cancer chemopreventives.[J].1999,8(5).
- [12]Leval X,Julemont F,Delarge J,etc.New trends in dual 5-LOX/COX inhibition.[J].2002,9(9).
- [13]H, Ikawa,H, Kamitani,B F, Calvo,etc.Expression of 15-lipoxygenase-1 in human colorectal cancer.[J].1999,59.
- [14]Alvaro Gracia JM.Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis.[J].2004,43(Suppl.1).
- [15]Liu ES,Wu WK,Cho CH,etc.Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking.[J].2004,203(1).
- [16]Sohn HY,Klauss V,Schiele TM,etc.Selective COX-2 inhibitors and risk of myocardial infarction.[J].2005,42(4).
- [17]S, Yamamoto.Mammalian lipoxygenases: molecular structures and functions.[J].1992,1128.
- [18]Sano H,Matsuyama M,Kawahito Y,etc.Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors.[J].2003,170(5).